Before you continue

🦠 Spore batteriche come micro-scudi: più stabilità per vaccini ed enzimi, nuove strade per biotecnologie accessibili e resistenti. #Scienza #Biotech

🔗 https://www.tomshw.it/scienze/queste-spore-batteriche-potrebbero-aiutare-vaccini-ed-enzimi

Queste spore batteriche potrebbero aiutare vaccini ed enzimi

Uno studio su JACS Au amplia da 12 a 33 le proteine di superficie usabili nelle spore batteriche, aprendo a enzimi, vaccini orali e sensori più stabili.

Tom's Hardware
Researchers at Leiden University Medical Center have isolated a rare CGAS gene mutation in long-lived families that delays cellular aging by dampening inflammation. Animal trials are up next. #Genetics #Science #Aging #Healthspan #Biotech #MedicalResearch
https://blazetrends.com/a-rare-gene-mutation-protects-long-lived-families-from-aging-what-it-means-for-human-healthspan/?fsp_sid=38911
A Rare Gene Mutation Protects Long-Lived Families From Aging: What It Means For Human Healthspan

Children of long-lived parents develop cardiometabolic diseases 13 years later than average. Now, researchers have isolated the exact CGAS gene mutation responsible for this extended healthspan.

Blaze Trends
Anthropic's hire of Jumper extends its life-sciences ambitions following a $400 million biotech investment in April. The move may reflect where AI coding expertise is being deployed as companies compete on enterprise applications. https://www.implicator.ai/nobel-laureate-john-jumper-leaves-google-deepmind-for-anthropic/ #AIScience #Biotech #LabNews
Nobel Laureate John Jumper Leaves DeepMind for Anthropic

A Nobel Prize winner just walked out of Google's top AI lab. John Jumper, who shared the 2024 chemistry Nobel for AlphaFold, is leaving Google DeepMind for Anthropic, one day after another Google star left for OpenAI. What Anthropic wants with a protein scientist is the surprise.

Implicator.ai
insitro CEO Daphne Koller explains how artificial intelligence is establishing a predictive framework for biology, leading to new ALS therapeutic targets with Bristol Myers Squibb. The technology allows pharmaceutical companies to bypass traditional trial-and-error R&D. #HealthTech #ArtificialIntelligence #Science #MedicalResearch #Biotech
https://blazetrends.com/daphne-koller-on-moving-from-pc-dos-to-ai-drug-discovery-with-insitro/?fsp_sid=37881
Daphne Koller on Moving from PC-DOS to AI Drug Discovery With insitro

insitro CEO Daphne Koller explains how AI is establishing a predictive framework for biology, leading to new ALS therapeutic targets with Bristol Myers Squibb.

Blaze Trends

In a massive technological upset, China’s National Medical Products Administration has officially granted the world’s first commercial approval for an invasive brain-computer interface beating Elon Musk’s Neuralink to the mass market.

#neurotech #braincomputerinterface #bci #neuralink #elonmuskquotes #technews #futuretech #biotech #neuroscience #chinatech

The Most Promising Ebola Vaccine Has Been Sitting on the Shelf for 15 Years

https://web.brid.gy/r/https://www.wired.com/story/ebola-vaccine-sitting-on-shelf-for-15-years/

The 3-Step Process of Platelet-Rich Plasma (PRP) 🧪🧬.

​ How exactly does a blood draw turn into a powerful joint repair treatment? We break down the clinical science behind PRP: from the initial draw and the high-speed centrifuge spin to the targeted injection that restarts your body’s healing timeline.

Https://regenstep.com/prp-platelet-rich-plasma-joint-repair/

#MedicalScience #HowItWorks #PRPInjection #CellularHealth #Biotech #HealthyLifestyle #Orthopedics #HealthEducation

A Londra parte entro fine anno il primo trial al mondo che prova a "ringiovanire" il sistema immunitario con un'iniezione. Le cellule T che ci difendono si stancano con l'età e smettono di funzionare: la molecola sviluppata dalla SenTcell dovrebbe rimetterle in moto.

Nei topi è andata bene, +70% di vita. Solo che chi ha inventato la molecola è anche il CEO della società. Per quanto abbia alle spalle recenti studi già convalidati, seguiamo con prudenza.

https://www.futuroprossimo.it/2026/06/uk-ringiovanimento-delle-cellule-immunitarie-al-via-la-fase-1/

#biotech

A flexible graphene-based neural interface can 'speak and listen' to the brain

https://lemmy.world/post/48309097

A flexible graphene-based neural interface can 'speak and listen' to the brain - Lemmy.World

Lemmy